User profiles for Jin Nakahara

Jin Nakahara

Department of Neurology, Keio University School of Medicine
Verified email at a6.keio.jp
Cited by 4425

Deschloroclozapine, a potent and selective chemogenetic actuator enables rapid neuronal and behavioral modulations in mice and monkeys

…, M Shimojo, MR Zhang, Y Tomita, J Nakahara… - Nature …, 2020 - nature.com
The chemogenetic technology designer receptors exclusively activated by designer drugs (DREADDs)
afford remotely reversible control of cellular signaling, neuronal activity and …

[HTML][HTML] Osteopetrosis and thalamic hypomyelinosis with synaptic degeneration in DAP12-deficient mice

T Kaifu, J Nakahara, M Inui, K Mishima… - The Journal of …, 2003 - Am Soc Clin Investig
Deletions in the DAP12 gene in humans result in Nasu-Hakola disease, characterized by a
combination of bone fractures and psychotic symptoms similar to schizophrenia, rapidly …

Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy

Y Watanabe, A Uruha, S Suzuki, J Nakahara… - Journal of Neurology …, 2016 - jnnp.bmj.com
Objective To elucidate the common and distinct clinical features of immune-mediated
necrotising myopathy (IMNM), also known as necrotising autoimmune myopathy associated with …

Current concepts in multiple sclerosis: autoimmunity versus oligodendrogliopathy

J Nakahara, M Maeda, S Aiso, N Suzuki - Clinical reviews in allergy & …, 2012 - Springer
Multiple sclerosis (MS) is an inflammatory demyelinating disease of the central nervous
system that affects millions of patients worldwide. The current disease-modifying therapies (DMTs…

[HTML][HTML] Abnormal expression of TIP30 and arrested nucleocytoplasmic transport within oligodendrocyte precursor cells in multiple sclerosis

J Nakahara, K Kanekura, M Nawa… - The Journal of …, 2008 - Am Soc Clin Investig
… observations also indicated that TIP30 is not induced in the demyelinated lesions observed
in animals with myelin oligodendrocyte glycoprotein (amino acids 1–125) EAE (Jin Nakahara

[HTML][HTML] Inflammatory myopathy with anti-signal recognition particle antibodies: case series of 100 patients

…, H Nishimura, Y Watanabe, J Nakahara… - Orphanet journal of rare …, 2015 - Springer
Background Anti-signal recognition particle (SRP) antibodies are used as serological
markers of necrotizing myopathy, which is characterized by many necrotic and regenerative …

Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study

…, Y Suzuki, S Ishida, S Suzuki, J Nakahara… - The Lancet …, 2023 - thelancet.com
Background Generalised myasthenia gravis is a chronic, unpredictable, and debilitating rare
disease, often accompanied by high treatment burden and with an unmet need for more …

Skeletal muscle involvement in antisynthetase syndrome

…, Y Ohnuki, J Tsugawa, Y Watanabe, J Nakahara… - JAMA …, 2017 - jamanetwork.com
Importance Antisynthetase syndrome, characterized by myositis, interstitial lung disease, skin
rash, arthropathy, and Raynaud phenomenon, is a clinical entity based on the presence of …

Electroconvulsive therapy for Parkinson's disease: A systematic review and meta‐analysis

…, M Seki, S Kudo, T Yoshizaki, J Nakahara… - Movement …, 2021 - Wiley Online Library
Background Electroconvulsive therapy (ECT) is a well‐established treatment for psychiatric
disorders, including depression and psychosis. ECT has been reported to be effective in …

[HTML][HTML] Predicting response to CGRP-monoclonal antibodies in patients with migraine in Japan: a single-centre retrospective observational study

…, K Ishizuchi, S Hori, R Takemura, J Nakahara… - The Journal of …, 2023 - Springer
Background Anti-calcitonin gene-related peptide monoclonal antibodies (CGRPmAbs) are a
favourable option for patients with migraine who experience distressful headache disability …